BhattHB,SmithRJ, 2015.Fatty liver disease in diabetes mellitus,Hepatobiliary Surg Nutr 4 101 -8
SrinivasanK,ViswanadB,AsratL,KaulC, 2005.Combination of high-fat diet-fed and low-dose streptozotocintreated rat: A model for type 2 diabetes and pharmacological screening,Pharmacol Res 52 313 -20
ArulB,KothaiR,ChristinaA, 2010.Hypoglycemic activity of casearia esculenta roxb in normal and diabetic albino rats,Iran J Pharm Res 47 -51
RanksPakistan,W., 2008.7th on diabetes prevalence list,The Nation -
CusiK., 2010.The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes,Curr Diab Rep 10 306 -15
SungKC,KimSH, 2011.Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes,J Clin Endocrinol Metab 96 1093 -7
UtzschneiderKM,KahnSE, 2006.The role of insulin resistance in nonalcoholic fatty liver disease,J Clin Endocrinol Metab 91 4753 -61
SongR, 2016.Mechanism of metformin: A tale of two sites,Diabetes Care 39 187 -9
ZafarM,NaqviSN, 2010.Effects of STZ-Induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: A comparative study,Int J Morphol 28 1 -
MasonT,ChanB,El-BahraniB,GohT,GuptaN,GambleJ, 2002.The effect of chronic insulin delivery via the intraperitoneal versus the subcutaneous route on hepatic triglyceride secretion rate in streptozotocin diabetic rats,Atherosclerosis 161 345 -52
LinHZ,YangSQ,ChuckareeC,KuhajdaF,RonnetG,DiehlAM, 2000.Metformin reverses fatty liver disease in obese, leptindeficient mice,Nat Med 6 998 -1003
TessariP,TiengoA, 2008.Metformin treatment of rats with dietinduced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver,Acta Diabetol 45 143 -5
KleinerDE,BruntEM,Van NattaM,BehlingC,ContosMJ,CummingsOW, 2005.Design and validation of a histological scoring system for nonalcoholic fatty liver disease,Hepatology 41 1313 -21
KnodellRG,IshakKG,BlackWC,ChenTS,CraigR,KaplowitzN, 1981.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis,Hepatology 1 431 -5
IshakK,BaptistaA,BianchiL,CalleaF,De GrooteJ,GudatF, 1995.Histological grading and staging of chronic hepatitis,J Hepatol 22 696 -9
KriskaA,DelahantyL,EdelsteinS,AmodeiN,ChadwickJ,CopelandK, 2013.Sedentary behaviour and physical activity in youth with recent onset of type 2 diabetes,Pediatrics 131 e850 -e6
KahnBB,FlierJS, 2000.Obesity and insulin resistance,J Clin Invest 106 473 -81
FaehD,MinehiraK,SchwarzJM,PeriasamyR,ParkS, 2005.Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men,Diabetes 54 1907 -13
LingvayI,RaskinP,SzczepaniakLS, 2007.Effect of insulinmetformin combination on hepatic steatosis in patients with type 2 diabetes,J Diabetes Complications 21 137 -42
MazzaA,FruciB,GarinisGA,GiulianoS,MalaguarneraR,BelfioreA, 2012.The role of metformin in the management of NAFLD,Exp Diabetes Res -
LingvayI,RoeED,DuongJ,LeonardD,SzczepaniakLS, 2012.Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes,J Investig Med 60 1059 -63
FurlongNJ,HulmeSA,O'brienSV,HardyKJ, 2002.Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy,Diabetes Care 25 1685 -90
JaberLA,NowakSN,SlaughterRR, 2002.Insulin-metformin combination therapy in obese patients with type 2 diabetes,J Clin Pharmacol New Drugs 42 89 -94